Insights into depression could aid development of new treatments

February 26, 2018, University of Edinburgh
Credit: CC0 Public Domain

Fresh insights into changes in the brain linked to depression could pave the way for new therapies.

The study also sheds light on why a certain category of stop working in some people.

Researchers at the University of Edinburgh pinpointed a key molecule that may protect the brain from depression.

The team studied mice that were bred to have defects in their ability to activate this molecule, called eIF4E.

These animals showed signs of depression, including reduced levels of the hormone serotonin, which is a hallmark of the condition.

The mice also showed behavioural changes linked to depression, such as disinterest in food.

Treatment with a commonly prescribed antidepressant called fluoxetine failed to produce a response in the mice.

This suggests that activation of eIF4E is required for the beneficial antidepressant effects of fluoxetine, which belongs to a category of medicines called selective serotonin re-uptake inhibitors (SSRIs).

Researchers say this could help explain why some patients stop responding to SSRIs.

Previous studies have shown that eIF4E plays a key role in regulating protein synthesis in the . Defects in eIF4E have been linked with other neurological conditions, including autism and Fragile X syndrome. This is the first time the molecule has been implicated in depression.

Experts say the latest findings could help develop new medications for , which affects about one in four people in the UK each year.

Explore further: New drug shows potential as a different kind of antidepressant in mouse trials

More information: Inês Silva Amorim et al, Loss of eIF4E phosphorylation engenders depression-like behaviors via selective mRNA translation, The Journal of Neuroscience (2018). DOI: 10.1523/JNEUROSCI.2673-17.2018

Related Stories

New drug shows potential as a different kind of antidepressant in mouse trials

November 6, 2017
A potential new antidepressant and antianxiety treatment with a unique mechanism of action has been developed by scientists at the University of Bath.

Novel mode of antidepressant action may help patients unresponsive to SSRIs

April 25, 2017
Antidepressants treat symptoms of depression by increasing levels of brain signaling molecules (neurotransmitters) such as serotonin, as with the most widely used type of antidepressant, selective serotonin reuptake inhibitors ...

Antidepressant bone loss could be prevented with beta-blockers

September 7, 2016
The antidepressant fluoxetine causes bone loss by instructing the brain to send out signals that increase bone breakdown, but a beta-blocker can intercept the signals, a new study in mice has found.

The science behind many antidepressants appears to be backwards, researchers say

February 18, 2015
The science behind many antidepressant medications appears to be backwards, say the authors of a paper that challenges the prevailing ideas about the nature of depression and some of the world's most commonly prescribed medications.

Why don't antidepressants work in some patients? Mouse study shows it may be down to your environment

September 20, 2016
SSRI antidepressants (Selective Serotonin Reuptake Inhibitors, the best known being Prozactm) are amongst the most commonly taken medicines. However, there seems to be no way of knowing in advance whether or not SSRIs will ...

Scientists find promise in intervention to normalize biological functions in Fragile X mice

November 7, 2017
A team of neuroscientists have developed an intervention that normalizes multiple biological functions in mice afflicted with Fragile X Syndrome (FXS). Its breakthrough centers on protein synthesis, or the building of proteins, ...

Recommended for you

Cell study reveals how head injuries lead to serious brain diseases

November 16, 2018
UCLA biologists have discovered how head injuries adversely affect individual cells and genes that can lead to serious brain disorders. The life scientists provide the first cell "atlas" of the hippocampus—the part of the ...

Newborn babies' brain responses to being touched on the face measured for the first time

November 16, 2018
A newborn baby's brain responds to being touched on the face, according to new research co-led by UCL.

Playing high school football changes the teenage brain

November 16, 2018
A single season of high school football may be enough to cause microscopic changes in the structure of the brain, according to a new study by researchers at the University of California, Berkeley, Duke University and the ...

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

New brain imaging research shows that when we expect something to hurt it does, even if the stimulus isn't so painful

November 14, 2018
Expect a shot to hurt and it probably will, even if the needle poke isn't really so painful. Brace for a second shot and you'll likely flinch again, even though—second time around—you should know better.

A 15-minute scan could help diagnose brain damage in newborns

November 14, 2018
A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.